Compare IRMD & FSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRMD | FSCO |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2014 | 2013 |
| Metric | IRMD | FSCO |
|---|---|---|
| Price | $91.76 | $5.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $116.00 | N/A |
| AVG Volume (30 Days) | 77.5K | ★ 1.4M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $11.99 | N/A |
| Revenue Next Year | $9.91 | N/A |
| P/E Ratio | $53.12 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $50.00 | $4.28 |
| 52 Week High | $107.90 | $7.65 |
| Indicator | IRMD | FSCO |
|---|---|---|
| Relative Strength Index (RSI) | 35.24 | 54.27 |
| Support Level | $69.54 | $4.87 |
| Resistance Level | $105.87 | $5.30 |
| Average True Range (ATR) | 2.95 | 0.12 |
| MACD | -0.42 | 0.04 |
| Stochastic Oscillator | 7.23 | 87.18 |
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests are typically rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.